GlassScriptPhysician profile
Misook Hong
NPI 1396106357
$4,190.68
in general payments reported to CMS, 2019-2025
30 companies · $763 in 2025
The $763 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $1,293 · 2023: $989 · 2024: $933 · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,684.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $379.60 | 2023-2025 | Ultomiris, Soliris |
| Amgen INC. | $369.11 | 2022-2025 | Evenity, Repatha |
| Abbvie INC. | $279.89 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $216.54 | 2023-2024 | Amvuttra, Givlaari |
| Glaxosmithkline, LLC. | $209.82 | 2022-2025 | Benlysta |
| Scynexis, INC. | $186.32 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $182.46 | 2023-2024 | Airsupra, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $160.39 | 2022 | |
| Novo Nordisk INC | $150.52 | 2022-2023 | Wegovy |
| Kestra Medical Technology Services, INC. | $136.95 | 2024 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $134.59 | 2024 | Spravato |
| Boston Scientific Corporation | $134.29 | 2025 | Watchman Flx |
| Biohaven Pharmaceutical Holding Company LTD. | $124.99 | 2022 | |
| Lundbeck LLC | $124.99 | 2024 | Vyepti |
| Astellas Pharma US INC | $122.06 | 2025 | Veozah |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $122.06 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $121.08 | 2022 | |
| Axsome Therapeutics, INC. | $112.43 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $110.20 | 2022 | |
| Edwards Lifesciences Corporation | $105.74 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.10 | 2024 | Lifevest |
| Pfizer INC. | $97.76 | 2023 | |
| Shield Therapeutics INC | $93.01 | 2022 | |
| Corcept Therapeutics | $86.90 | 2021 | |
| Sage Therapeutics, LLC | $86.12 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.95 | 2023 | |
| Sk Life Science, INC. | $72.07 | 2022 | |
| Molnlycke Health Care US, LLC | $50.74 | 2023 | Mepilex Border Em, Mepilex Border Flex, Mepilex Border Sacrum |
| Medtronic, INC. | $31.44 | 2023 | Intellis Adaptivestim |
| Optinose US, INC. | $14.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misook Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.